Aim The aim of this review is to inform the reader on the latest developments in
epidemiology, diagnostics and management. Epidemiology Drug-resistant Tuberculosis (DR …

Background A substantial proportion of tuberculosis patients remain with pulmonary
symptoms and reduced physical capacity despite successful treatment. We performed a …

Background Information on tuberculosis (TB) and coronavirus disease 2019 (COVID-19) is
still limited. The aim of this study was to describe the features of the TB/COVID-19 co …

Page 1 WHO Module 4: Treatment Drug-susceptible tuberculosis treatment operational
handbook on tuberculosis World Health Organization Page 2 WHO operationa handbook …

TB affects around 10.6 million people each year and there are now around 155 million TB
survivors. TB and its treatments can lead to permanently impaired health and wellbeing. In …

BACKGROUND: Optimal drug dosing is important to ensure adequate response to
treatment, prevent development of drug resistance and reduce drug toxicity. The aim of …

BACKGROUND: Tuberculosis (TB) preventive therapy (TPT) decreases the risk of
developing TB disease and its associated morbidity and mortality. The aim of these clinical …

Background Longitudinal cohort data of patients with tuberculosis (TB) and coronavirus
disease 2019 (COVID-19) are lacking. In our global study, we describe long-term outcomes …

In 2020, an estimated total of 155 million people had survived tuberculosis. Among this
number, a sizable proportion have considerable post-tuberculosis morbidity, as shown for …

Background Emerging evidence suggests that after completion of treatment for tuberculosis
(TB) a significant proportion of patients experience sequelae. However, there is limited …